Patient-centric dose equivalency pilot study of incobotulinumtoxin a (xeomin) vs. abobotulinumtoxin a (dysport) in the treatment of glabellar frown lines

Original Article

|Open Access
Article Access Statistics
  • Viewed

    5049

  • Downloaded

    80

Table of Contents
Plastic and Aesthetic Research Print ISSN: 2347-9264; Online ISSN: 2349-6150
Partners
Copyright © 2018 OAE Publishing Inc. All Rights Reserved.